$AIFC Balance Sheet | Understand Stock

$AIFC

$0.28 +$0.01 (3.31%) Close

$AIFC Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 27, 2026	Q1 FY2026 As of Mar 28, 2026	Q4 FY2025 As of Dec 27, 2025	Q3 FY2025 As of Sep 27, 2025	Q2 FY2025 As of Jun 28, 2025	Q1 FY2025 As of Mar 29, 2025	Q4 FY2024 As of Dec 28, 2024	Q3 FY2024 As of Sep 28, 2024	Q2 FY2024 As of Jun 29, 2024	Q1 FY2024 As of Mar 30, 2024	Q4 FY2023 As of Dec 30, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jul 1, 2023	Q1 FY2023 As of Apr 1, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Oct 1, 2022	Q2 FY2022 As of Jul 2, 2022	Q1 FY2022 As of Apr 2, 2022	Q4 FY2021 As of Jan 1, 2022	Q3 FY2021 As of Oct 2, 2021
Cash
Short term investment
Trade and other receivables, net
Income taxes receivable
Inventories
Continuing Operations
Total inventories
Digital assets receivable
Prepaid expenses and other current assets
Other current assets
Current assets from discontinued operations
Total current assets
Intangible assets - Soin, net
Continuing Operations
Soin Therapeutics LLC Member
Total intangible assets - Soin, net

Other intangible assets, net
Note receivable - VM7, net
Note receivable - SPYR, net
Property and equipment, net
Continuing Operations
Total property and equipment, net

Right of use assets
Intangible assets, net
Series S Convertible Preferred Stock
Total intangible assets, net
Marketable securities
Deposits and other assets
Cryptocurrency assets at fair value
Deferred income taxes, net
Goodwill
Other assets from discontinued operations
Total assets
Accounts payable
Accrued liability - California sales taxes
Short term debt
Current portion of note payable
Related party note
Due to Soin
Related Party
Total due to Soin
Accrued liabilities - other
Digital assets payable
Convertible debentures
Operating lease liabilities
Notes payable
Nonrelated Party
Related Party
Total notes payable
Current liabilities from discontinued operations
Total current liabilities
Long-term portion related party note payable
Related party notes payable
Other noncurrent liabilities
Noncurrent liabilities from discontinued operations
Total liabilities
Convertible preferred stock, series S - par value $0.001 per share 200,000 authorized, 100,000 shares issued and outstanding at June 27, 2026 and December 27, 2025
Series S Convertible Preferred Stock
Series S
Total convertible preferred stock, series S - par value $0.001 per share 200,000 authorized, 100,000 shares issued and outstanding at June 27, 2026 and December 27, 2025
Stockholders’ equity:
Convertible preferred stock, series S - par value $0.001 per share 200,000 authorized,100,000 and 100,000 shares issued and outstanding at April1,2023 and December 31,2022, respectively.
Preferred stock,value
Series S
Series A-1 Preferred
Series S
Series A-1 Preferred
Series B
Series M
Series A1 Convertible Preferred Stock
Series S Convertible Preferred Stock
Series A Preferred Stock
Series B Preferred Stock
Series I Convertible Preferred Stock
Series M Preferred Stock
Series S
Series V Convertible Preferred Stock
Series I Convertible Preferred Stock
Series M Preferred
Series V Convertible Preferred Stock
Series M Preferred Stock
Series Q Convertible Preferred Stock
Series Q Preferred Stock
Total preferred stock,value
Common stock, par value $0.001 per share, 2,000,000,000 shares authorized, 139,836,511 and 126,474,169 shares issued and outstanding at June 27, 2026 and at December 27, 2026, respectively
Treasury stock, at cost, 674,651 and 0 shares outstanding at June 27, 2026 and December 27, 2026
Accumulated other comprehensive loss
Additional paid-in capital
Accumulated deficit
Equity attributable to AI Financial Corporation shareholders
Noncontrolling interest
Total stockholder’s equity
Total liabilities, mezzanine equity and stockholders’ equity

Comments